Inflammatory indices are associated with non-suicidal self-injury in adolescents with major depressive disorder Authors: Wenxuan Zhang, Yuhan Zhang, Tianmei Xu, Ye Wang, Enyan Yu, Jing Yue Published: 2025 ABSTRACT AbstractBackgroundThe neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-lymphocyte ratio (PLR), and C-reactive protein (CRP)-albumin ratio (CAR) constitute peripheral inflammatory indices. This study aimed to evaluate the correlation between these inflammatory indices and non-suicidal self-injury (NSSI) behavior in adolescents with major depressive disorder (MDD).MethodsAdolescents diagnosed with MDD were enrolled in this study. All participants underwent psychological and biochemical assessments and were classified into two groups based on the presence or absence of NSSI. NLR, MLR, PLR, and CAR were calculated from complete blood counts.ResultsA total of 101 adolescents with MDD were included. No significant differences were observed in the demographic data between the groups. The NSSI group had significantly higher levels of white blood cells, neutrophils, NLR, MLR, and CAR, and lower albumin levels than the non-NSSI group. Multivariate regression analysis revealed that NLR and MLR were independently associated with NSSI. The proposed cut-off values were NLR = 1.23 (sensitivity = 70.2% and specificity = 59.1%) and MLR = 0.14 (sensitivity = 77.2% and specificity = 43.2%).ConclusionsSystemic inflammation may play a role in NSSI among adolescents with MDD. NLR and MLR, as cost-effective and easily accessible indices, are associated with NSSI, but further longitudinal studies are required to determine their predictive value.Clinical trial numberNot applicable.Keywords: Non-suicidal self-injury, Major depressive disorder, Neutrophil-lymphocyte ratio, Monocyte-lymphocyte ratio, Platelet-lymphocyte ratio, CRP-albumin ratio Background Major depressive disorder (MDD) is a leading contributor to the global burden of disease, profoundly affecting patient daily lives and resulting in significant social dysfunction [1]. Additionally, MDD is a major risk factor for non-suicidal self-injury (NSSI) [2], involving deliberate self-infliction of harm without suicidal intent, including behaviors such as cutting, burning, bruising, biting, and scratching [3]. Numerous studies have shown that NSSI is the strongest predictor of future suicidal behavior, with patients with MDD who engage in NSSI being at particularly high risk for potential suicide [4, 5]. Epidemiological research indicates that MDD onset peaks between the ages of 15–29 years, with MDD being the second leading cause of death among adolescents worldwide [6]. A meta-analysis involving 41 countries reported that approximately 22.9% of adolescents have engaged in NSSI [7]. The incidence of NSSI is significantly higher among adolescents with MDD than in the general adolescent population [8, 9]. MDD and NSSI not only increase the consumption of medical resources but also have a huge impact on the social economy. The annual economic burden of MDD in the United States has been estimated to be 326 billion dollars, with direct medical costs accounting for about 37% and indirect costs (such as lost productivity) accounting for an even larger share [10]. Therefore, adolescents with MDD who engage in NSSI constitute a high-risk group for suicide and represent a significant public health concern. Recent years have seen increasing interest in the role of inflammatory responses in the pathophysiology of mood disorders. Growing evidence suggests that low-grade systemic inflammation may contribute to the onset and progression of depression by inducing oxidative stress damage, increasing glutamatergic excitotoxicity, and affecting the activity of neuronal serotonin transporters [11, 12]. A large meta-analysis of 37 studies found that 27% of patients with depression had low-grade inflammation (CRP >3.0 mg/L) [13], supporting the concept of MDD as an immune-inflammatory disorder. Against this background, several easily accessible peripheral blood indices have been widely investigated. The neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), and high-sensitivity C-reactive protein (hs-CRP) have been identified as simple and stable clinical indices of systemic inflammation and have been investigated in various neuropsychiatric disorders [14, 15]. In 2017, Kayhan et al. indicated that higher PLR values were associated with depression severity [16]. Additionally, a meta-analysis in 2018 revealed that NLR and PLR values in patients with MDD or bipolar disorder (BD) were significantly higher than those in healthy individuals in the same age group [17]. CRP is widely used as a measure of low-grade inflammation. The ratio of CRP to albumin (CAR) is a novel biomarker reflecting systemic inflammation and nutritional status. Studies have shown that CAR is associated with poorer cardiovascular outcomes, increased incidence of diabetic complications, lower survival rates in patients with cancer, higher tumor invasiveness, and poorer treatment responses [18, 19]. However, research on the role of CAR in neuropsychiatric disorders remains limited. A recent systematic review summarized evidence linking peripheral inflammatory markers with suicidal ideation, attempts, and death, supporting the hypothesis that immune dysregulation may contribute to self-harm behaviors [20]. However, most of these studies were conducted in mixed-age or adult populations and focused on suicidal outcomes rather than NSSI, leaving the role of systemic inflammation in adolescent NSSI within the context of MDD unclear. Currently, studies on the relationship between NSSI and inflammatory responses are sparse and inconsistent. In 2024, Bai et al. discovered a significant association between interleukin-6 (IL-6) and NSSI but a weaker link between CRP and NSSI [21]. This contrasts with the findings of Russel et al. in 2020, who reported a negative correlation between CRP and NSSI, suggesting that higher CRP levels may have a protective effect against NSSI [22]. One possible explanation for these counterintuitive findings is that low CRP levels reflect an increased susceptibility to early infection, while elevated CRP levels may reflect a more robust anti-inflammatory response or a compensatory mechanism to reduce stress-related immune disorders [23]. Despite these findings, the specific association between NSSI and inflammatory indices in adolescents with MDD remains unclear. For example, Puangsri et al.[24] reported that NLR and PLR were elevated in drug-naïve adolescents with MDD and may serve as biomarkers for depression and suicide risk, whereas Zheng et al. [25] found elevated MLR and PLR levels in adolescents with NSSI. However, these studies either investigated inflammatory indices in MDD without focusing on NSSI or examined NSSI irrespective of psychiatric diagnosis. Our study aimed to examine the differences in NLR, MLR, PLR, hs-CRP, and CAR between adolescents with MDD with and without NSSI, thereby clarifying the unique inflammatory profile associated with NSSI in this clinically important subgroup. These findings may provide novel biological insights to aid in the early identification and intervention of this high-risk population. Methods Participants This was a cross-sectional study. Participants were selected using convenience sampling from adolescents aged 12 to 18 years who were hospitalized in the Clinical Psychology Department of Zhejiang Provincial People’s Hospital between September 2024 and March 2025. All participants were first-diagnosed MDD patients who had not previously received treatment. To ensure the ethical inclusion of underage participants, informed consent was obtained from both the adolescents and their legal guardians before participation. The study procedures were fully explained, and participants had the opportunity to ask questions before providing written consent. All participants were required to meet the following inclusion criteria: (1) a diagnosis of MDD according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V), confirmed through clinician-administered semi-structured diagnostic interviews conducted by two experienced psychiatrists [18]; (2) presence or absence of a history of NSSI, defined according to DSM-5 criteria as recurrent, intentional self-inflicted harm (e.g., scratching, pinching, gouging) occurring at least five times within the past year, resulting in mild to moderate physical damage without suicidal intent. A history of NSSI was determined using information collected through direct interviews with participants and review of their medical records; (3) a Hamilton Depression Rating Scale-24 (HDRS-24) score of ≥ 24 and a Self-Rating Depression Scale (SDS) score of ≥ 60 [26]. Patients with MDD were divided into two groups based on NSSI diagnosis: MDD with NSSI and MDD without NSSI. The study was approved by the Ethics Committee of Zhejiang Provincial People’s Hospital, and (Ethical Application Ref: QT2024205). The exclusion criteria were as follows: (1) individuals with organic brain diseases, intellectual disabilities, or inability to perform hematological tests or scale assessments; (2) individuals with comorbid psychiatric diagnoses, acute infections, subclinical infections, active or chronic inflammation, autoimmune diseases, and chronic liver or kidney diseases; (3) those who had used anti-inflammatory drugs, antipyretic analgesics, immunosuppressants, or glucocorticoids within the past 2 weeks. All participants who met the inclusion criteria and did not meet any exclusion criteria were enrolled, and no participants were excluded after screening. Data collection Clinical and demographic data were obtained through medical records and standardized psychological assessments conducted by trained psychiatrists. Regarding blood collection, Participants were asked to fast early in the morning on the day of blood collection, and 5 mL of fasting venous blood was collected from participants. The samples were centrifuged at 4,000 rpm for 10 min to isolate the supernatant. A fully automated biochemical analyzer (AU5831, Beckman Coulter, USA) was used to measure the complete blood count, including the WBC count, monocyte count, lymphocyte count, neutrophil count, platelet count, CRP, and albumin. NLR, MLR, PLR, and CAR were calculated. Cases with incomplete clinical, psychological, or inflammatory marker data were excluded from the analysis to ensure data integrity. Assessments Hamilton depression rating scale-24 The HDRS-24 is a widely used, clinician-administered questionnaire assessing the severity of depression in individuals already diagnosed with the disorder. The scale was developed by Hamilton in 1960 and constitutes a series of questions covering various symptoms of depression, including mood, feelings of guilt, suicidal ideation, insomnia, work and activities, psychomotor agitation or retardation, anxiety, weight loss, and somatic symptoms [27]. Zhao et al. demonstrated that the scale exhibited high inter-rater reliability, with a Fleiss’ kappa value of 0.92, and demonstrated good internal consistency, with a Cronbach’s alpha of 0.714 [28]. Each item is scored on a scale ranging from 0 to 2 or 0–4, with higher scores indicating more severe depression. Depressive symptom severity is subsequently categorized as no depression or within the normal range (≤ 7 points), mild depression (8–16 points), moderate depression (17–23 points), and severe depression (≥ 24 points). Self-rating depression scale The SDS, first proposed by Zung in 1965, was used to assess depressive symptoms [29]. This scale quantifies and evaluates the severity of depressive symptoms using patient self-reports. The primary aim of the SDS is to provide a simple yet effective means of assessing depressive symptoms in clinical and research settings, particularly in psychiatric outpatient and inpatient settings. Gabrys et al. reported that the scale demonstrated strong inter-rater agreement, with a Fleiss’ kappa of 0.89, and satisfactory internal consistency, as indicated by a Cronbach’s alpha of 0.88 [30]. The SDS comprises 20 items, each rated according to the frequency of symptoms, with scores ranging from 1 to 4. The severity of depressive symptoms is classified as normal (< 50 points), mild depression (50–59 points), moderate depression (60–69 points), or severe depression (≥ 70 points) based on the scoring criteria [31]. Statistical analysis Statistical analysis was performed utilizing SPSS version 25.0. Numerical variables were summarized as mean ± standard deviation (SD) and categorical variables as frequencies and percentages. The Shapiro–Wilk test was employed to ascertain the normality of the variables. Regarding normally distributed data, an independent two-sample t-test was applied to compare groups. Regarding non-normally distributed data, the Mann–Whitney U test was utilized for intergroup comparisons. Categorical variables and frequencies were analyzed using the chi-squared (χ2) test. Furthermore, receiver operating characteristic (ROC) curve analysis was conducted to establish optimal cut-off values for indices in detecting NSSI. All statistical tests were considered significant at a two-tailed P-value threshold of < 0.05. Results Overall, 101 patients were included in this study, with 57 in the NSSI group and 44 in non-NSSI group. The mean age of the NSSI group was 15.53 years, comprising 45 females and 12 males, whereas that of non-NSSI group was 15.59 years, comprising 30 females and 14 males. Statistical analyses revealed no significant differences between the two groups regarding age, sex, family history, body mass index (BMI), SDS score, or HDRS-24 score (all P > 0.05). The choice of statistical tests was based on the distribution of data, as assessed by the Shapiro–Wilk test. The demographic characteristics of the study participants are summarized in Table 1. Table 1Characteristics of the study participantsVariablesNSSI (n = 57)Non-NSSI (n = 44)P-valueAge (years)15.53 ± 1.50115.59 ± 1.560.833Female, n (%)45 (78.9%)30 (68.2%)0.220Family history4 (7.0%)0 (0%)0.201BMI (kg/m2)21.73 ± 4.03520.94 ± 4.4060.351SDS76.21 ± 7.38473.35 ± 9.2180.086HDRS-2433.21 ± 5.83631.07 ± 5.8600.071BMI, Body mass index; SDS, Self-Rating Depression Scale; HDRS-24, Hamilton Depression Rating Scale-24; NSSI, non-suicidal self-injury Characteristics of the study participants BMI, Body mass index; SDS, Self-Rating Depression Scale; HDRS-24, Hamilton Depression Rating Scale-24; NSSI, non-suicidal self-injury The WBC count (P = 0.006), neutrophil count (P = 0.001), NLR(P = 0.001), MLR (P = 0.023), and CAR (P = 0.028) were significantly higher in adolescents with NSSI than in those without NSSI. hs-CRP (P = 0.050) and Monocytes (P = 0.055) showed a borderline significant difference. The albumin count was significantly lower in the NSSI group (P = 0.001) (Table 2). Table 2Comparison of blood count parameters between the MDD with NSSI and MDD without NSSI groupsVariablesNSSINon-NSSIT/ZP-valueWBC (109/L)6.49 (4.11–9.88)a5.77 (2.93–11.70)a-2.767 0.006 c Monocyte (109/L)0.41 (0.23–0.81)a0.36 (0.11–0.64)a-1.916 0.055 c Neutrophil (109/L)3.54 (1.44–6.38)a2.82 (1.38–6.67)a-3.425 0.001 c Lymphocyte (109/L)2.32 ± 0.562.41 ± 0.64-0.8010.425bPlatelet (109/L)265.20 ± 52.89254.07 ± 47.470.9080.366bhs-CRP (mg/L)0.835 (0–7.1)a0.686 (0–5.7)a-1.963 0.050 c Albumin (g/dL)4.31 ± 0.264.53 ± 0.32-3.499 0.001 b NLR1.64 (0.54–4.90)a1.21 (0.50–2.89)a-3.216 0.001 c PLR121.94 (57.14–359.76)a112.18 (59.49–217.76)a-1.1540.248cMLR0.19 (0.07–0.55)a0.15 (0.07–0.27)a-2.277 0.023 c CAR0.19 (0–1.62)a0.16 (0–1.31)a-2.204 0.028 c a Expressed as median (lower–upper quartiles), b T-test, c Mann–Whitney U testNLR, Neutrophil–lymphocyte ratio; PLR, Platelet-lymphocyte ratio; MLR, Monocyte-lymphocyte ratio; CAR, CRP-Albumin ratio; WBC, white blood cells; MDD, major depressive disorder; NSSI, non-suicidal self-injury Comparison of blood count parameters between the MDD with NSSI and MDD without NSSI groups a Expressed as median (lower–upper quartiles), b T-test, c Mann–Whitney U test NLR, Neutrophil–lymphocyte ratio; PLR, Platelet-lymphocyte ratio; MLR, Monocyte-lymphocyte ratio; CAR, CRP-Albumin ratio; WBC, white blood cells; MDD, major depressive disorder; NSSI, non-suicidal self-injury We used NSSI (1 = yes, 0 = no) as the dependent variable in the logistic regression model. Multivariate logistic regression analysis showed that only NLR (odds ratio [OR] 4.726, 95% confidence interval [CI]: 1.888–11.830, P = 0.001) and MLR (OR 3.798, 95% CI: 1.544–9.340, P = 0.004) were significantly associated with NSSI, after controlling for confounding variables (age, sex, BMI) (Table 3). Table 3A logistic regression model for the associations between NSSI and inflammatory markersVariablesOR(95% CI)P-valueNLR4.726 (1.888–11.830) 0.001 MLR3.798 (1.544–9.340) 0.004 CAR1.221 (0.264–5.643)0.798Note: ORs represent odds ratios adjusted for age, sex, and BMI. NLR, Neutrophil–lymphocyte ratio; MLR, Monocyte-lymphocyte ratio; CAR, CRP-Albumin ratio; NSSI, non-suicidal self-injury; OR, Odds ratio; CI, Confidence interval A logistic regression model for the associations between NSSI and inflammatory markers Note: ORs represent odds ratios adjusted for age, sex, and BMI. NLR, Neutrophil–lymphocyte ratio; MLR, Monocyte-lymphocyte ratio; CAR, CRP-Albumin ratio; NSSI, non-suicidal self-injury; OR, Odds ratio; CI, Confidence interval ROC curve analyses were performed to assess the effectiveness of the NLR and MLR in predicting NSSI in adolescents with MDD. According to the ROC curve analysis, the area under the curve was 0.687 (95% CI: 0.584, 0.790, P = 0.001) for NLR and 0.633 (95% CI: 0.525, 0.740, P = 0.023) for MLR. The optimal cut-off values were as follows: 1.513 for NLR, with a sensitivity of 52.6% and a specificity of 82.8%; and 0.173 for MLR, with a sensitivity of 50.9% and a specificity of 75.0% (Fig. 1). ROC curves of NLR and MLR for prediction of NSSI. Diagonal dotted line represents the reference line (AUC = 0.5), indicating no discriminative ability. ROC, receiver operating characteristic; NLR, Neutrophil–lymphocyte ratio; MLR, Monocyte-lymphocyte ratio; NSSI, non-suicidal self-injury Discussion This study is the first to explore the association between NSSI behavior and inflammatory markers such as CAR, PLR, NLR, and MLR in the context of adolescents with MDD, adding novel insights into the inflammatory profiles of adolescents with MDD and NSSI. The results showed that adolescents with MDD who engaged in NSSI had significantly higher CAR, NLR, and MLR values. Notably, NLR and MLR were associated with NSSI, after adjusting for age, sex, and BMI, whereas CAR was not significantly associated with NSSI. This indicates that NLR and MLR are independent factors influencing NSSI in adolescents with MDD and have a potential role in the clinical evaluation of NSSI. Neutrophils are the primary responding cells in inflammation, promoting phagocytosis and apoptosis mainly through enhancing inflammatory mediators, whereas lymphocytes are associated with immune regulation and anti-inflammatory responses [26]. The NLR reflects the balance between two different but complementary components of the immune system. The NLR has been studied in various fields, including autoimmune diseases, malignancies, cardiovascular diseases, and neuropsychiatric disorders [32, 33]. Several studies have confirmed NLR elevation in patients with schizophrenia, MDD, and bipolar disorder [17, 34, 35]. Few recent studies have focused on adolescents, and the results of these studies are similar to those obtained from adult samples [36]. One recent study found that adolescents with depression had a significantly higher NLR than the control group, whereas no significant difference was observed in PLR [37]. However, the 2022 study by Zheng et al. found no correlation between NLR and NSSI in adolescents with mood disorders [25]. Their study analyzed adolescents with various mood disorders as a single group, without distinguishing specific diagnoses, which may obscure the distinct relationships between MDD and inflammatory markers. NSSI is frequently linked to stressful events, wherein the hypothalamic-pituitary-adrenal (HPA) axis plays a pivotal role in mediating responses to these stressors [38]. Animal studies show that stress leads to sustained neutrophil elevation [39], suggesting a link between stress, inflammation, and self-injury. This study is the first to specifically examine the association between NLR and NSSI in adolescents with MDD, supporting the hypothesis that stress-induced immune activation may contribute to NSSI in this population. Monocytes play a key role in innate immunity and inflammation [40]. The MLR has been suggested as a novel marker of low-grade inflammation and has been used as a prognostic score for systemic inflammation in diseases such as cancer, coronary heart disease, and pancreatitis [36]. Elevated MLR may contribute to neuroinflammation by increasing monocyte-related cytokines, activating microglia, and affecting neuroplasticity, impairing emotional regulation and cognitive function [25, 26]. Patients with NSSI also exhibit higher pain tolerance, potentially owing to altered endogenous opioid levels. Lower plasma β-endorphin in adolescents with NSSI may enhance monocyte-driven inflammation, similar to immune dysregulation observed in opioid use disorder [41–43]. The results of this study are generally consistent with previous studies. A 2021 study of 193 subjects by Puangsri et al. found that suicide attempts in patients with MDD were associated with higher monocyte counts and MLR, and compared to NLR and PLR, MLR demonstrated superior predictive ability for suicide attempts in this population and may serve as a potential biomarker [24]. A 2022 study by Zheng et al. showed that high MLR levels in young individuals appeared to be associated with self-harm [25]. In addition, Dadouli et al. found similar results in BD patients with significantly elevated levels of neutrophils, which they suggested could be attributed to low-grade inflammation or psychological stress [44]. These findings suggest that increased MLR may reflect a shared inflammatory pathway underlying both NSSI and suicide risk in adolescents with MDD. Hs-CRP is a widely used marker of low-grade inflammation in mental disorders, while albumin reflects nutritional status and can be suppressed by inflammation, leading to hypoalbuminemia [45]. CAR integrates both markers and has been used to assess systemic inflammation in cancer, rheumatoid arthritis, and cardiovascular diseases [19, 46]. Previous studies have established a link between CRP and depression. A large cohort study by Tayefi et al. (2017) found that hs-CRP levels were increased with depression severity [47], and Liu et al. (2024) further reported elevated hs-CRP in MDD patients, linked to gut microbiota disturbances [48]. However, no prior study has examined the relationship between CAR and NSSI. Our results showed significant differences in hs-CRP, albumin, and CAR levels between the NSSI and non-NSSI groups. However, after controlling for confounding factors, the predictive power of CAR appeared weaker. This may reflect the influence of nutritional status, such as irregular eating habits or malnutrition in adolescents with NSSI, which may contribute to lower albumin levels beyond inflammation. Given that lower albumin may exacerbate oxidative stress and depressive symptoms [49], future studies should better account for nutritional status when assessing CAR in MDD and NSSI. Overall, this study provides preliminary evidence for the relationship between CAR and NSSI, highlighting the need for further research to clarify its clinical relevance. A sensitivity-prioritized approach is crucial in public health and preventive medicine, because higher sensitivity enhances early disease detection. Based on our findings, we recommend adjusting the NLR cutoff for NSSI risk assessment to 1.23, increasing sensitivity to 70.2% with a slight reduction in specificity (59.1%). Similarly, adjusting the MLR cutoff to 0.14 improved sensitivity (77.2%) but reduced specificity (43.2%). Notably, Zheng et al. proposed a similar MLR cutoff (0.135) for NSSI diagnosis, with higher sensitivity (90.6%) but lower specificity (33.7%) [25]. While these inflammatory markers show potential associations with NSSI, their reliability as standalone biomarkers remains uncertain due to their fluctuations from acute stress or transient infections. Longitudinal studies are needed to enhance their predictive utility and clinical applicability. This study had some limitations. First, the use of convenience sampling from a single inpatient site may limit the generalizability of our findings to community or outpatient populations. Second, NLR, MLR, and CAR, although widely used, may not fully capture the complex inflammatory processes in MDD with NSSI. Future studies should incorporate cytokines such as IL-6 and TNF-α for a more comprehensive analysis. Third, the cross-sectional design prevents causal inferences. Longitudinal studies are needed to determine baseline inflammation levels and track temporal changes in these markers. Fourth, participants were not systematically assessed for Borderline Personality Disorder (BPD), a condition closely linked to NSSI, which should be addressed in future research. Fifth, the lack of a healthy control group limits the interpretation of inflammatory changes. Future studies including healthy controls are needed to clarify these effects. In addition, the severity or frequency of NSSI episodes was not assessed. Future studies should incorporate validated tools to quantify the severity of NSSI, which may provide more nuanced insights. Finally, important potential confounders that can affect systemic inflammation—such as smoking status, nutritional status, sleep patterns, and subclinical infections—were not systematically collected and should be addressed in future studies. Conclusions This study found that MDD adolescents with NSSI displayed altered markers of inflammation, with elevated NLR and MLR emerging as independent factors associated with NSSI. These findings suggest that inexpensive, readily available inflammatory indices may aid in identifying high-risk individuals and serve as candidate predictors for longitudinal risk models. Future studies with larger cohorts are warranted to validate these findings and explore their predictive and diagnostic potential. Acknowledgements We would like to thank Editage for the English language editing. Abbreviations Bipolar disorder Borderline Personality Disorder Ratio of CRP to albumin C-reactive protein High-sensitivity C-reactive protein Major depressive disorder Monocyte-to-lymphocyte ratio Neutrophil-to-lymphocyte ratio Non-suicidal self-injury Platelet-to-lymphocyte ratio Self-Rating Depression Scale Author contributions WZ. conducted the statistical analysis, interpreted the data, and drafted the manuscript. YZ. contributed to data collection and assisted in data analysis. TX. participated in the literature review and provided support in manuscript preparation. YW. critically reviewed the manuscript. EY. supervised the study design, guided data interpretation, and revised the manuscript. JY. conceived the study, provided overall supervision, and made substantial contributions to manuscript revision. All authors read and approved the final manuscript. Funding This work was supported by the Key Research and Development Project of Zhejiang Provincial (2021C03106). Data availability The datasets generated and analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate The study was approved by the Ethics Committee of Zhejiang Provincial People’s Hospital (Ethical Application Ref: QT2024205) and conducted in accordance with the Declaration of Helsinki. The committee reviewed the protocol and granted a waiver of informed consent because all data were de-identified and posed no additional risk to patients. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Enyan Yu, Email: yuenyan97@163.com. Jing Yue, Email: yuejing2008happy@163.com. References Associated Data Data Availability Statement The datasets generated and analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.